Cloudflare’s ‘terrific’ quarter lifts stock by 8%
[ad_1] The cybersecurity and software company deemed its second quarter “terrific” and guided for better times ahead. [ad_2] Source link
Echoes of the dot-com bubble haunt U.S. stocks in 2024. Why investors shouldn’t worry too much about it.
[ad_1] Jeremy Grantham’s GMO said it doesn’t make sense to draw a parallel between today’s so-called Magnificent Seven and their equivalents during the boom-and-bust cycle
Trump’s wish for tax-free Social Security is so reckless it’s almost funny
[ad_1] True, the Republican former president never drained the swamp. Maybe he’ll have a chance to drain the Treasury. [ad_2] Source link
Kellanova stock climbs on top- and bottom-line beats, plus lifted outlook
[ad_1] Shares of Kellanova rose 4.6% premarket after the food giant reported better-than-expected second-quarter results and raised its 2024 outlook. [ad_2] Source link
USA Today parent Gannett’s stock tumbles 10% after revenue falls short of estimates
[ad_1] Gannett Co. Inc.’s stock rose 2.9% early Thursday, after the USA Today publisher beat second-quarter profit estimates by a wide margin, offsetting a revenue
Mortgage rates fall to a five-month low as Fed signals possible September cut. How much lower will 30-year rates fall — and when?
[ad_1] Will mortgage rates drop significantly in the coming months, with the Fed potentially cutting rates in the near future? Four economists weigh in. [ad_2]
I’m skipping the iPhone 16 upgrade cycle — and refusing to give up my battered iPhone 12. Sorry, Apple. I’ll wait until it falls apart.
[ad_1] “I’m flying the flag for the filthy beauty of used iPhones.” [ad_2] Source link
Crocs’s stock drops on Q3 profit warning
[ad_1] The footwear maker has seen a 44% gain this year in its share price. [ad_2] Source link
Shell beats expectations as cost-cutting plans boost profitability
[ad_1] The British energy giant increased its profits in the face of lower oil and gas prices, as it successfully cut its costs by $700
Moderna’s stock slides 12% after it lowers full-year sales guidance
[ad_1] The second-quarter sales decline was mostly due to lower demand for the company’s COVID-19 vaccine. [ad_2] Source link